Pathway enrichment analysis based on DEGs between the two groups illustrated that there may be a regulatory relationship between CHRNA9 and the JAK/STAT signaling pathway during the progression of glioma disease, and CHRNA9 has been shown to activate STAT329. This evidence concerns the gene CHRNA9 and glioma.